In the press

James Carthew comments on voting at GSF’s upcoming AGM

Biotech trusts top performance charts in February

James Carthew comments on voting at the GSF AGM in Michael Nelson’s article:

“While the recent results were disappointing, I struggle to see how us shareholders would achieve a decent upside from a liquidation,”

Read the article here